Cargando…

Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis

In this study, we demonstrate, for the first time, that Saccharomyces cerevisiae-based probiotic shows an inhibitory effect on Gardnerella vaginalis infection. This effect is likely due to several actions: direct interference with adherence to vaginal tissues, inhibition of sialidase activity, reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbatini, Samuele, Monari, Claudia, Ballet, Nathalie, Mosci, Paolo, Decherf, Amélie Cayzeele, Pélerin, Fanny, Perito, Stefano, Scarpelli, Paolo, Vecchiarelli, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037478/
https://www.ncbi.nlm.nih.gov/pubmed/29683763
http://dx.doi.org/10.1080/21505594.2018.1464362
_version_ 1783338334798479360
author Sabbatini, Samuele
Monari, Claudia
Ballet, Nathalie
Mosci, Paolo
Decherf, Amélie Cayzeele
Pélerin, Fanny
Perito, Stefano
Scarpelli, Paolo
Vecchiarelli, Anna
author_facet Sabbatini, Samuele
Monari, Claudia
Ballet, Nathalie
Mosci, Paolo
Decherf, Amélie Cayzeele
Pélerin, Fanny
Perito, Stefano
Scarpelli, Paolo
Vecchiarelli, Anna
author_sort Sabbatini, Samuele
collection PubMed
description In this study, we demonstrate, for the first time, that Saccharomyces cerevisiae-based probiotic shows an inhibitory effect on Gardnerella vaginalis infection. This effect is likely due to several actions: direct interference with adherence to vaginal tissues, inhibition of sialidase activity, reduction of vaginal epithelial exfoliation. Gardnerella vaginalis does not induce vaginal inflammation and no inflammatory cytokines were, indeed, produced, by the mouse vagina, neither by Gardnerella vaginalis and by the probiotic. Collectively, our data incite to further investigations on Saccharomyces cerevisiae probiotic as a potential prophylactic or therapeutic agent in the vaginosis caused by Gardnerella vaginalis.
format Online
Article
Text
id pubmed-6037478
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-60374782018-07-11 Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis Sabbatini, Samuele Monari, Claudia Ballet, Nathalie Mosci, Paolo Decherf, Amélie Cayzeele Pélerin, Fanny Perito, Stefano Scarpelli, Paolo Vecchiarelli, Anna Virulence Research Paper In this study, we demonstrate, for the first time, that Saccharomyces cerevisiae-based probiotic shows an inhibitory effect on Gardnerella vaginalis infection. This effect is likely due to several actions: direct interference with adherence to vaginal tissues, inhibition of sialidase activity, reduction of vaginal epithelial exfoliation. Gardnerella vaginalis does not induce vaginal inflammation and no inflammatory cytokines were, indeed, produced, by the mouse vagina, neither by Gardnerella vaginalis and by the probiotic. Collectively, our data incite to further investigations on Saccharomyces cerevisiae probiotic as a potential prophylactic or therapeutic agent in the vaginosis caused by Gardnerella vaginalis. Taylor & Francis 2018-05-29 /pmc/articles/PMC6037478/ /pubmed/29683763 http://dx.doi.org/10.1080/21505594.2018.1464362 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Sabbatini, Samuele
Monari, Claudia
Ballet, Nathalie
Mosci, Paolo
Decherf, Amélie Cayzeele
Pélerin, Fanny
Perito, Stefano
Scarpelli, Paolo
Vecchiarelli, Anna
Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
title Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
title_full Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
title_fullStr Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
title_full_unstemmed Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
title_short Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
title_sort saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037478/
https://www.ncbi.nlm.nih.gov/pubmed/29683763
http://dx.doi.org/10.1080/21505594.2018.1464362
work_keys_str_mv AT sabbatinisamuele saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT monariclaudia saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT balletnathalie saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT moscipaolo saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT decherfameliecayzeele saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT pelerinfanny saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT peritostefano saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT scarpellipaolo saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis
AT vecchiarellianna saccharomycescerevisiaebasedprobioticasnovelantimicrobialagentfortherapyofbacterialvaginosis